Follicular Lymphoma Market Size Anticipates Growth as the Key Companies Explores Novel Therapeutics Assets
Follicular lymphoma, a sub-type of indolent B cell non-Hodgkin lymphoma (NHL), accounts for approximately 20% of the total NHL cases. It is the most frequently diagnosed indolent lymphoma. On average, each year, 15,000 new Follicular lymphoma cases are diagnosed in the US alone. DelveInsight estimated that in 2020 there were 35,737 prevalent cases of Follicular […]